The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAMP.L Regulatory News (AMP)

  • There is currently no data for AMP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Partner Company - Product Launch

17 Sep 2008 07:00

RNS Number : 5981D
Amphion Innovations PLC
17 September 2008
 



Amphion Innovations plc Partner Company, Kromek, Confirms the Near Completion of Scanning Systems 

to Enhance Airport Security Procedures

London and New York, 17 September 2008 Amphion Innovations plc (LSE: AMP) ("Amphion" or the "Company"), the developer of companies in the medical and technology sectors, today announces that its Partner Company, Kromek, the developer of digital colour imaging for use in x-rays and scanners, has confirmed it will be launching two products for use in airports in the coming months.

Upcoming products include:

A Threat Liquid Detection system using a digital colour x-ray detector for the rapid identification of liquid inside a bottle, removing the need to open the bottle or sample the liquid. This product will be launched in November in Dubai and in December in Washington and is used for scanning single bottles.

A 311+ Scanner using the same technology to scan for any threat liquids contained in 311 bags (plastic bags which are used for carrying small bottles of liquid in aircrafts). This product will be launched within the next five months.

Kromek is also pioneering the development of 3D, colour x-ray imaging using its unique capability in semiconductors and imaging systems which will significantly enhance the existing baggage screening application. These new baggage screening systems will have the ability to produce 3D images of a bag, giving operators a much better visualization of objects inside and will automatically identify any threat material using new generation detectors and advanced algorithms unique to Kromek.

Kromek is currently carrying out the development of its baggage imaging systems in conjunction with the UK Home office and is in talks with a number of parties for licensing this technology. 

Richard Morgan, Amphion Chief Executive Officer, said "We are pleased to be able to announce the launch of Kromek's first two commercially available products, which is an exciting milestone not only for the company but also for airport security systems worldwide."

Dr Arnab Basu, Chief Executive Officer of Kromek said:

'Kromek is proud to be working alongside bodies such as the UK Home office in the development of scanners for the detection of prohibited liquids. These systems are aimed at enhancing the high levels of security already existing at UK airports, while at the same time greatly adding to passenger convenience and reducing time spent in transit.' 

For further information please contact

Amphion Innovations plc Charlie Morgan, Director of Communications +1 212 210 6224 (New York)

Cardew Group Tim Robertson/ Jamie Milton/ Matthew Law +44 020 7930 0777 (London

Charles Stanley Securities - Nominated Adviser  Mark Taylor / Freddy Crossley +44 20 7149 6000

About Amphion Innovations plc Amphion (LSE: AMP) builds shareholder value in high growth companies in the medical and technology sectors, by using a focused, hands-on company building approach, based on decades of experience in both the US and UK. Amphion has significant shareholding in 10 Partner Companies developing proven technologies targeting substantial commercial marketplaces, each in excess of $1 billion. Each Partner Company is chosen with the goal of achieving an exit valuation in excess of $100 million.

On the web: www.amphionplc.com

About Kromek

Kromek is a venture backed high technology company, which was spun-out in April 2003 as Durham Scientific Crystals, from the Physics Department of the University of Durham. Rebranded as Kromek in May 2008, its pioneering digital colour imaging for x-rays has brought ground-breaking innovation to materials technology and advanced 3D imaging that will literally change the way in which we see the world.

The Company specialises in making semiconductor materials within the Cadmium Telluride family. These materials have significant applications as detectors of x-rays and gamma rays, notably in medical imaging, security screening, industrial inspection and space exploration, allowing for very precise identification of materials. Cadmium Zinc Telluride is also the material of choice as a substrate for the fabrication of infrared detectors in both civilian and military markets. In addition to its range of semiconductor materials, detector packages and non imaging detection systems Kromek also supplies x-ray imaging packages with multi view capabilities. These x-ray display platforms provide real 3D x-ray imaging for the first time without specialist viewing equipment. 

On the web: www.kromek.com 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAUNRBRWURKAAR
Date   Source Headline
31st Dec 20191:15 pmRNSAmphion Innovations
31st Dec 201912:36 pmRNSCancellation of trading on AIM
20th Nov 20197:00 amRNSDirectors' Dealings and Business Update
18th Oct 20197:00 amRNSSettlement of loan facility
11th Oct 20197:01 amRNSPolarean notes statement from Amphion Innovations
11th Oct 20197:00 amRNSSale of Partner Company Shares
3rd Oct 20197:00 amRNSSale of Partner Company Shares
25th Sep 20197:00 amRNSAmended Terms on Loan Facility
10th Sep 20194:56 pmRNSSale of Partner Company Shares
9th Aug 20194:14 pmRNSStatement on Amphion Innovations
9th Aug 20194:14 pmRNSDirectorate Change
9th Aug 20193:51 pmRNSSale of Partner Company Shares
1st Jul 20197:30 amRNSSuspension - Amphion Innovations Plc
27th Jun 20193:00 pmRNSAnnual Report and Accounts Update
14th Jun 20199:04 amRNSHolding(s) in Company
12th Jun 20197:00 amRNSLoan facility update
31st May 201910:28 amRNSHolding(s) in Company
20th May 20196:14 pmRNSHolding(s) in Company
1st Apr 20194:40 pmRNSSecond Price Monitoring Extn
1st Apr 20194:35 pmRNSPrice Monitoring Extension
1st Apr 20197:00 amRNSUpdate on Loan Facility
20th Mar 20197:00 amRNSHolding(s) in Company
19th Mar 20192:33 pmRNSSale of Partner Company Shares
18th Mar 20192:00 pmRNSPrice Monitoring Extension
15th Mar 20197:01 amRNSHolding(s) in Company
15th Mar 20197:00 amRNSSale of Partner Company Shares
11th Mar 20194:41 pmRNSAmended Terms on Loan Facility
26th Feb 20197:00 amRNSConvertible Promissory Note Extended
14th Feb 20198:00 amRNSStatement re. Motif Bio plc
7th Feb 20199:40 amRNSStmnt re Share Price Movement
1st Feb 20197:00 amRNSAppointment of Joint Broker
21st Jan 20197:00 amRNSWellGen Finalises License Agreement
11th Dec 20187:05 amRNSInvestment in Polarean & Loan Facility Repayment
16th Oct 20187:00 amRNSExtended Repayment and Draw Down on Loan Facility
28th Sep 20187:00 amRNSHalf-year Report
5th Sep 20187:00 amRNSBoard Change
23rd Aug 20183:20 pmRNSPolarean update
21st Aug 20187:15 amRNSMotif Bio notes statement from Amphion Innovations
21st Aug 20187:00 amRNSSale of Partner Company Shares
1st Aug 20184:47 pmRNSResult of AGM
29th Jun 20187:00 amRNSDirectorate Change
26th Jun 20187:00 amRNSFinal Results
23rd May 20187:00 amRNSMotif Bio notes statement from Amphion Innovations
23rd May 20187:00 amRNSSale of Partner Company Shares
20th Apr 20187:00 amRNSDirectorate Change
29th Mar 20187:00 amRNSAIM Admission & First Day of Dealings
29th Mar 20187:00 amRNSUpdate on Polarean Imaging IPO
26th Mar 20187:31 amRNSUpdate on Polarean Imaging proposed AIM IPO
2nd Mar 20187:00 amRNSConvertible promissory note extended to December
10th Jan 20185:09 pmRNSDirector dealing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.